Chengdu, China · Founded 2016 · Privately Held (backing)
Developer of targeted therapeutic and diagnostic agents for nuclear medicine applications. Newrite Medical is based in Chengdu, China and was founded in 2016. Its last reported valuation was $32.7 million in Aug 2018. It has raised $331 million.
Last reported valuation
$32.7M
Oct 2026
Priced at
—
Total raised
$330.9M
Last round
—
Cap table — not yet on record
Newrite Medical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Newrite Medical with a free account
·The complete investor list: 28 names
·Watch Newrite Medical: the Monday email on marks, rounds and moves
